In 2026, Isomorphic Labs raised $2.1 billion in its Series B financing, making it the largest investment to date in an AI drug discovery company.
That single financing round exceeded the total venture capital invested in European biotech companies th...
Want to read this article? Subscribe to TFN Prime at super early discounted price